Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Warning message

The subscription service is currently unavailable. Please try again later.

News

The Value of MIPI and Ki-67 in Mantle Cell Lymphoma

Thursday, December 28, 2017

 John P. Leonard, M.D., interim chair of the Department of Medicine, associate dean of clinical research, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, professor of medicine, hosts a panel discussion on the topic of Mantle Cell Lymphoma International Prognostic Index. The Index evaluates four components (age, leukocytosis, lactate dehydrogenase, and performance status) under three categories: high risk, intermediate risk, and low risk.